Jupiter Neurosciences, Inc. (JUNS)

0.4295 -0.01 (-1.76%) USD  |  NASDAQ  |  Apr 20, 16:00
0.4295 0.00 (0.00%) After-Hours: 17:48
More

Jupiter Neurosciences SG&A Expense (Quarterly) : 2.783M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for JUNS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Aethlon Medical, Inc. 0.7416M
Tonix Pharmaceuticals Holding Corp. 35.68M
Phio Pharmaceuticals Corp. 1.057M
Jaguar Health, Inc. 7.164M
MetaVia, Inc. 1.805M